Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
World Dairy Expo 2024 World Dairy Expo 2024
Not Confirmed
Not Confirmed
01-04 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
World Dairy Expo 2024 World Dairy Expo 2024
Industry Trade Show
Not Confirmed
01-04 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
30 Mar 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/complix-and-vib-publish-pioneering-study-on-cell-penetrating-alphabodies-in-science-advances-301258629.html
30 Mar 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/gemvaxs-highly-promising-phase-ii-alzheimers-disease-clinical-trial-results-targeting-telomerase-published-in-prestigious-alzheimers-research--therapy-journal-301258354.html
23 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/gemvax--kael-reports-further-positive-data-from-gv1001-phase-ii-alzheimers-disease-trial-301178368.html
23 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/gemvax--kael-reports-further-positive-data-from-gv1001-phase-ii-alzheimers-disease-trial-301178368.html
06 Oct 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/promising-phase-ii-results-underpin-gemvax-decision-to-apply-for-expanded-access-ind-for-gv1001-in-alzheimers-disease-301146372.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?